T0	Limitation 23103 23105	We
T1	Limitation 23883 23891	Although
T2	Limitation 24291 24293	We
T3	VerySpecificPopulation 23185 23261	the relatively low plasma concentrations of TNF-α in this cohort of patients
T4	Population 23949 24056	confounding factors such as those related to pharmacokinetic and pharmacodynamic variation between subjects
T5	NonstandardTreatmentCharacteristics 24061 24102	the effects of concurrent medical therapy
T6	Intervention 24330 24441	more rapid treatment (within the first 24 h) and higher doses of etanercept may have produced different results
